Table 3.
Correlations between SMI, ASM%, and serum biomarkers.
| All (n = 64) | Men (n = 56) | Women (n = 8) | ||||
|---|---|---|---|---|---|---|
| SMI | ASM% | SMI | ASM% | SMI | ASM% | |
| Albumin | ||||||
| Spearman’s corr. (r) | 0.229 | 0.179 | 0.147 | 0.104 | 0.593 | 0.272 |
| p-value | 0.069 | 0.157 | 0.279 | 0.447 | 0.121 | 0.515 |
| Partial corr. (r)a | 0.217 | 0.141 | 0.143 | 0.071 | 0.738 | 0.114 |
| p-value | 0.087 | 0.271 | 0.297 | 0.607 | 0.058 | 0.807 |
| Partial corr. (r)b | 0.082 | 0.151 | −0.023 | 0.081 | 0.765* | 0.198 |
| p-value | 0.524 | 0.236 | 0.868 | 0.557 | 0.045 | 0.671 |
| Partial corr. (r)c | 0.072 | 0.116 | −0.034 | 0.036 | 0.763 | 0.248 |
| p-value | 0.579 | 0.369 | 0.809 | 0.795 | 0.078 | 0.636 |
| Transthyretin | ||||||
| Spearman’s corr. (r) | 0.246 | 0.132 | 0.208 | 0.048 | 0.048 | −0.857** |
| p-value | 0.050 | 0.297 | 0.124 | 0.725 | 0.911 | 0.007 |
| Partial corr. (r)a | 0.237 | 0.101 | 0.204 | 0.002 | 0.030 | −0.839* |
| p-value | 0.061 | 0.433 | 0.135 | 0.987 | 0.949 | 0.018 |
| Partial corr. (r)b | 0.213 | 0.120 | 0.142 | 0.033 | 0.075 | −0.874 |
| p-value | 0.094 | 0.349 | 0.302 | 0.808 | 0.872 | 0.010 * |
| Partial corr. (r)c | 0.206 | 0.090 | 0.134 | −0.017 | 0.054 | −0.889* |
| p-value | 0.109 | 0.484 | 0.335 | 0.901 | 0.919 | 0.018 |
| Alanine aminotransferase (ALT) | ||||||
| Spearman’s corr. (r) | 0.271* | 0.209 | 0.144 | 0.048 | 0.190 | 0.095 |
| p-value | 0.030 | 0.098 | 0.289 | 0.726 | 0.651 | 0.823 |
| Partial corr. (r)a | 0.261* | 0.175 | 0.141 | 0.023 | 0.200 | 0.051 |
| p-value | 0.039 | 0.170 | 0.304 | 0.868 | 0.668 | 0.913 |
| Partial corr. (r)b | 0.158 | 0.186 | −0.032 | 0.016 | 0.193 | 0.106 |
| p-value | 0.216 | 0.144 | 0.819 | 0.917 | 0.678 | 0.820 |
| Partial corr. (r)c | 0.150 | 0.156 | −0.040 | −0.020 | 0.277 | −0.016 |
| p-value | 0.245 | 0.226 | 0.776 | 0.886 | 0.596 | 0.977 |
| Aspartate aminotransferase (AST) | ||||||
| Spearman’s corr. (r) | 0.038 | 0.181 | −0.169 | −0.001 | 0.238 | 0.190 |
| p-value | 0.766 | 0.152 | 0.213 | 0.993 | 0.570 | 0.651 |
| Partial corr. (r)a | 0.034 | 0.176 | −0.171 | −0.013 | 0.236 | 0.339 |
| p-value | 0.791 | 0.168 | 0.212 | 0.927 | 0.610 | 0.457 |
| Partial corr. (r)b | −0.017 | 0.168 | −0.275* | −0.018 | 0.277 | 0.290 |
| p-value | 0.897 | 0.188 | 0.042 | 0.895 | 0.547 | 0.528 |
| Partial corr. (r)c | −0.019 | 0.165 | −0.279* | −0.033 | 0.279 | 0.313 |
| p-value | 0.825 | 0.199 | 0.041 | 0.812 | 0.592 | 0.546 |
| AST/ALT ratio | ||||||
| Spearman’s corr. (r) | −0.360** | −0.089 | −0.386** | −0.031 | −0.048 | 0.000 |
| p-value | 0.003 | 0.484 | 0.003 | 0.823 | 0.911 | 1.00 |
| Partial corr. (r)a | −0.351** | −0.043 | −0.384** | −0.001 | −0.117 | 0.361 |
| p-value | 0.005 | 0.736 | 0.004 | 0.997 | 0.803 | 0.427 |
| Partial corr. (r)b | −0.264* | −0.054 | −0.285* | −0.002 | −0.025 | 0.135 |
| p-value | 0.036 | 0.675 | 0.035 | 0.986 | 0.958 | 0.773 |
| Partial corr. (r)c | −0.257* | −0.011 | −0.281* | 0.037 | −0.139 | 0.393 |
| p-value | 0.044 | 0.932 | 0.040 | 0.792 | 0.793 | 0.441 |
| C-terminal agrin fragment | ||||||
| Spearman’s corr. (r) | −0.042 | −0.180 | −0.008 | −0.161 | 0.429 | 0.286 |
| p-value | 0.741 | 0.154 | 0.956 | 0.235 | 0.289 | 0.493 |
| Partial corr. (r)a | −0.029 | −0.146 | −0.002 | −0.133 | 0.429 | 0.303 |
| p-value | 0.823 | 0.253 | 0.988 | 0.334 | 0.337 | 0.509 |
| Partial corr. (r)b | −0.048 | −0.182 | −0.015 | −0.163 | 0.436 | 0.311 |
| p-value | 0.706 | 0.152 | 0.912 | 0.234 | 0.329 | 0.497 |
| Partial corr. (r)c | −0.038 | −0.148 | −0.008 | −0.134 | 0.476 | 0.277 |
| p-value | 0.770 | 0.250 | 0.955 | 0.333 | 0.340 | 0.595 |
Bold values indicate statistical significance (p < 0.05). corr., correlation; ASM%, appendicular skeletal muscle; SMI, skeletal muscle index (kg m−2). Non-parametric partial correlations are corrected for (a) high-sensitivity C-reactive protein, (b) age, and (c) high-sensitivity C-reactive protein and age.
p < 0.05;
p < 0.01.